Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-07-29

Clinical Trial Update: HIV Levels in Cerebrospinal Fluid and Brain Function in Patients Receiving Anti-HIV Drugs

View source ↗

Summary

A completed clinical trial investigated HIV levels in cerebrospinal fluid and their relationship to brain function in patients receiving anti-HIV drugs.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Cognitive Disorders, HIV Infections | Status: COMPLETED